Matt Mauney > Goodwin > Washington DC, United States > Lawyer Profile
Goodwin Offices
1900 N Street NW
Washington, District of Columbia 20036
United States
- Firm Profile
- Go to...
Matt Mauney
Position
Partner
Career
Matt Mauney is a partner in Goodwin’s Private Equity group. He advises public and private companies as well as private equity and venture capital firms on a wide array of complex business transactions, including structuring and negotiating strategic and leveraged acquisitions and divestitures, mergers and acquisitions, cross-border transactions, venture capital and growth equity investments, equity and debt financings, recapitalizations and restructurings, executive compensation and incentive equity matters, and general corporate counseling and compliance. Matt has worked with both middle-market and upmarket clients on transactions ranging in size from several million dollars to billions of dollars. He has extensive experience working in a variety of industries, including regulated industries such as healthcare and banking.
Education
JD, Vanderbilt University Law School / BS, Computer Science & Government, Georgetown University
Lawyer Rankings
United States > M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
(Next Generation Partners)Lawyer Rankings
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation